Americans are okay with gene-editing embryos to create healthier babies
The US public approves of gene-tailored babies but fears that the wealthy will use the technology first, leading to inequality.
The survey: The Pew Research Center asked 2,537 US adults how they felt about changing the genetic characteristics of babies using gene-editing tools.
Wide public support: Surprise. Seven out of 10 people said they think changing a baby’s genes is an appropriate use of technology, but only if it’s to treat or avoid a serious disease.
But only for healthy tots: When asked, only 20 percent thought making “more intelligent” humans would be acceptable. Most believed that using gene editing to increase intelligence would be taking things “too far.”
Top fear: Americans may be generally okay with genetically modified babies, but they still think negative results are more likely than positive ones. Survey respondents ranked inequality as their top worry. More than half think it’s “very likely” that gene-edited babies will only be available to the wealthy.
Deep Dive
Biotechnology
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Forget designer babies. Here’s how CRISPR is really changing lives
The gene-editing tool is being tested in people, and the first treatment could be approved this year.
Neuroscientists listened in on people’s brains for a week. They found order and chaos.
The study shows that our brains exist between chaos and stability—a finding that could be used to help tweak them either way.
More than 200 people have been treated with experimental CRISPR therapies
But at a global genome-editing summit, exciting trial results were tempered by safety and ethical concerns.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.